The results demonstrated that tRF-T36 mimic significantly increased caspase-3 activity by approximately 2-fold after 18 h treatment in both CRC cell lines (Fig. 3D), which correlates with the results from qPCR assay. This evidence concerns the gene CASP3 and colorectal carcinoma.